Skin, Hair, and Nail Care with News

Posts for tag: Dupixent (dupilumab)

Dr. Jonathan Schreiber, PhD is relieved to report a "great, new treatment" for his moderate-to-severe Eczema (Atopic Dermatitis) patients with Dupixent (dupilumab), the FDA's new biologic injection announced today.  Research has shown psoriasis's immune-driven model can be applied to reverse Eczema, click images to connect to Dr. Emma Guttman-Yassky, MD, PhD speech at the American Academy of Dermatology event.

Taking Care of Tidewater ~ See the Difference with Us!

Emma Guttman-Yassky, MD, PhD: “This is proof the disease is reversible, an immune-driven disease, like psoriasis. This is a game-changer and a life-changer.”